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levels (r=0.57, p=0.06).
Conclusion: This finding suggests that glucose-lowering treatment in type 2 diabetes
beneficially influences the coronary circulatory function. The significant increase of MBF
responses to CPT may be related to the extent of lowered glucose plasma levels. This
improvement may result directly from lowering plasma glucose levels and/or antidiabetic
agents.
3:00 p.m.
816-5 Progression of Coronary Artery Disesase in Diabetics 
Demonstrated by Single Isotope Rest/Stress Tc-99m 
Sestamibi Myocardial Perfusion Imaging: More Rapid 
Than Nondiabetics?
Gavin L. Noble, Sachin M. Navare, Syed A. Hussain, Deborah M. Katten, Alan W. 
Ahlberg, Jacob Calvert, William E. Boden, Gary V. Heller, Hartford Hospital, Hartford, CT
Background: Patients with Diabetes Mellitus (DM) have increased cardiac risk com-
pared to Non-Diabetics (Non-DM), even after normal myocardial perfusion imaging.
Objective: To evaluate the progression of CAD in diabetics with known or suspected
CAD who received serial MPI.
Methods: The Hartford Hospital database was queried to obtain all patients with known
or suspected CAD with Tc-99m rest/stress myocardial perfusion imaging studies from
1996-2001 (N=9581). DM and Non-DM were evaluated for patients undergoing repeat
studies (DM =217, Non-DM=507), as well as the number converting from normal MPI to
abnormal (fixed and reversible).
Results: Retesting occurred in 16.8% (217/1291) and 9.3% (517/5587) of DM and Non-
DM with normal MPI (p<0.0001). Of those retested, 32.7% (71/217) of DM and 23.4% of
Non-DM (121/517) converted from normal to abnormal (p<0.009). Of all with normal MPI,
5.5% of DM and 2.2% of Non-DM were sent for re-testing and converted to abnormal
(p<0.0001, OR 2.63 {1.93,3.58}. 1.9% of DM and 1.0% of Non-DM (p=0.022, OR 1.80
{1.08, 2.97}) had cardiac death or non-fatal MI and were not included in the analysis of
retesting. The cumulative cardiac death/MI/conversion rates were 7.4% and 3.2% for DM
and Non-DM respectively (p<0.0001, OR 2.4{1.84,3.12}). Inter-test interval was 2.2 ± 1.3
years (p=ns)
Conclusion: CAD progresses more rapidly in patients with diabetes. Symptom based
surveillance is able to identify patients at increased risk.
3:15 p.m.
816-6 Prevalence of Silent Ischemia in Diabetic Patients With 
Subclinical Atherosclerosis: Detection by Stress 
Myocardial Perfusion Imaging
Vijay D. Anand, Susan Fourie, David Hopkins, Patrick Sharp, Avijit Lahiri, Northwick Park 
Hospital, London, United Kingdom, Cardiac Imaging and Research Centre, Wellington 
Hospital, London, United Kingdom
Background: Patients with diabetes mellitus have accelerated atherosclerosis and
increased cardiovascular morbidity and mortality. Hence the detection of significant coro-
nary artery disease before the occurrence of coronary events is desirable in this patient
group.We evaluated the prevalence of silent myocardial ischaemia in asymptomatic dia-
betic patients with moderate to severe subclinical atherosclerosis detected by Electron
Beam Tomography (EBT).
Methods: We prospectively studied 275 asymptomatic patients with type 2 diabetes. 73
patients (26.5%)(mean age +/-SD: 57 +/-7,80% men) with moderate atherosclerotic
plaque burden (coronary calcium score[CCS] >100 Agatston units) were evaluated fur-
ther by Tc99m sestamibi SPECT. We compared the prevalence of silent ischaemia in this
group with a randomly selected control group of asymptomatic non-diabetic patients with
similar cardiovascular risk factor profiles and CCS (n = 77).
Results: Diabetic patients with moderate plaque burden had a higher prevalence (40%
vs 17%, chi square statistic = 4.78, p = 0.029) and extent of myocardial ischaemia(mean
summed stress score [SSS] +/- SD in diabetics: 2.4 +/- 3.8 vs mean SSS in non diabet-
ics: 1+/- 2.5, p = 0.04) in comparison to non-diabetics with the same CCS. The above dif-
ferences were attenuated in patients with a higher plaque burden (CCS>400). 
Conclusion: A lower CCS threshold (CCS>100) may be used to identify asymptomatic
diabetic patients who have silent myocardial ischaemia.
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1112-141 Determinants of Visual 2-D Echo Assessment of Left 
Ventricular Wall Motion: Comparison With Myocardial 
Thickening on Cardiac Magnetic Resonance Imaging
Charles A. Nelson, Jane McCrohon, Stephen Rose, Thomas Marwick, University of 
Queensland, Brisbane, Australia
Background: left ventricular wall motion on 2d echo (2de) is usually scored visually. we
sought to examine the determinants of visually assessed wall motion scoring on 2de by
comparison with myocardial thickening quantified on MRI.
Methods: using a 16 segment model, we studied 287 segments in 30 patients aged 61+/
-11 years (6 female), with ischaemic LV dysfunction (defined by at least 2 segments dys-
functional on 2de). 2de was performed in 5 views and wall motion scores (WMS)
assigned: 1 (normal) 103 segments, 2 (hypokinetic) 93 segments, 3 (akinetic) 87 seg-
ments. MRI was used to measure end systolic wall thickness (ESWT), end diastolic wall
thickness (EDWT) and percentage systolic wall thickening (SWT%) in the plane of the
2de and to assess WMS in the same planes visually. No patient had a clinical ischemic
event between the tests.
Results: visual assessment of wall motion by 2de and MRI showed moderate agreement
(kappa = 0.425). Resting 2de wall motion correlated significantly (p<0.01) with ESWT(-
0.345), EDWT(-0.379) and SWT%(-0.334).
Conclusion: SWT% and ESWT decrease with increasing WMS. However, the distinction
between hypo and akinesis appears to correlate better with ESWT than SWT% or EDWT.
1112-142 Prediction of Right Ventricular Ejection Fraction From 
Doppler Tei Index
Shiro Yoshifuku, Yutaka Otsuji, Koichi Kihara, Masanori Tsurugida, Satoshi Yoshino, 
Shinichi Minagoe, Chuwa Tei, Fujimoto-Hayasuzu Hospital, Miyakonojyo, Japan, 
Kagoshima University School of Medicine, Kagoshima, Japan
Background: Measurement of right ventricular (RV) ejection fraction (EF) is not neces-
sarily feasible due to the complicated geometry. Tei index, defined as the sum of isovolu-
metric contraction and relaxation time (ICT and IRT) divided by ejection time, is a non-
geometric measure of ventricular function, which can be applied to the RV. We hypothe-
sized that RV Tei index has significant correlation with RV EF. Therefore, the purpose of
this study was to evaluate the feasibility of RV Tei index to predict EF. Methods: RV Tei
index by Doppler echocardiography as (a-b)/b, where a is the interval between cessation
and onset of tricuspid flow and b is the pulmonary flow ejection time, and RV ejection
fraction by TC - 99m cardiac pool scintigraphy (first pass method) were measured in 25
patients with clinically suspected RV dysfunction (19 with ischemic heart disease, 2 with
biventricular dysfunction, 2 with interstitial pneumonia, and 2 with mitral stenosis). RV EF
< 40% was defined as reduced RV EF. Results: 1) RV Tei index has good and significant
relation with RV ejection fraction (R = -0.81, P < 0.0001). 2) Diagnosis of reduced RV EF
by Tei index > 0.44 had the sensitivity, specificity, and accuracy of 88%, 94%, and 92%,
respectively. Conclusion: RV Tei index enables simple and feasible prediction of RV
ejection fraction. 
Patient Category Myocardial Perfusion Imaging (MPI)
Abnormal MPI Normal MPI
Non-diabetic (CCS: 100-400) 10(17%) 48(83%)
Diabetic (CCS: 100-400) 14(40%) 21(60%)
Non-diabetic (CCS>400) 8(44%) 10(56%)
Diabetic (CCS>400) 25(66%) 13(34%)
1 (normal) 2 (hypokinetic) 3 (akinetic) p ANOVA p (2 vs 3)
EDWT 9.2±2.4 mm 9.2±2.1 mm 8.4±1.5 mm <0.0001 0.07
ESWT 12.8±3.0 mm 11.3±3.1 mm 9.9±3.2 mm <0.0001 0.003
SWT % 47±41 24±24 21±31 <0.0001 0.481
JACC March 3, 2004 ABSTRACTS - Noninvasive Imaging  341A
Noninvasive Im
aging
1112-143 Chronic Effect of Cardiac Resynchronization Therapy 
on Functional Mitral Regurgitation in the Advanced 
Systolic Heart Failure
Kazuya Murata, Rikimaru Oyama, Nobuaki Tanaka, Yasuyuki Hatano, Eizo Akagawa, 
Akihiko Shimizu, Masunori Matsuzaki, Yamaguchi University, Ube, Japan
Acute and chronic effects of cardiac resynchronization therapy (CRT) on functional mitral
regurgitation (FMR) in severe systolic heart failure and thier mechanisms were not still
elucidated. Nine severe heart failure patients with wide QRS complex duration
(>140msec) and FMR received CRT were studied. pical 4- and 2-chamber views were
obtained by tissue Doppler imaging before and one week and 6 months after CRT. Total
Eight regions of interest were placed on mid and base of IVS, posterior, anterolateral and
inferior wall. Time interval from end-diastole to the timing of peak systolic velocity (T-Sm)
in each ROI was obtained and coefficient of variation (CV=standard deviation/mean) of T-
Sm was calculated as an index of LV asynchrony. Mitral valve area (MVA:cm2) and mitral
leaflet tethering lengths defined as the distance between the papillary muscle tips and
the contralateral anterior mitral annulus were measured in the apical 4- and 2-chamber
views and sum of tethering lengths (TLs) was obtained. LV sphericity index (SI: ratio of
LV short- to long-axis dimension in apical four chamber view) was estimated. MR regur-
gitant fraction (MRF:%) was calculated by pulsed Doppler method. Results: CV and
MRF tended to improve one week after CRT (from 0.33 to 0.16, from 64 to 61%, respec-
tively), although LV dimension and MVA unchanged. Six months after CRT, CV and SI
improved (from 0.33 to 0.14 %, from 0.74 to 0.71, P<0.05, respectively) and TLs short-
ened (from 87 to 76mm, P<0.01). MVA and MRF also improved 6 months after CRT(from
9.5 to 8.1cm2, from 64 to 57%, P<0.05, respectively) .Conclusion: In addition to the
improvement of LV synchronicity, the improvement of LV sphericity and tethering effect
caused by reverse remodeling of dilated LV played an important role for reduction of FMR
in chronic phase after CRT.
1112-144 Evaluation of Left Ventricular Function in Pediatric 
Sickle Cell Anemia Patients Using the End Systolic Wall 
Stress-VCFc Relationship
Luke Lamers, Greg Ensing, Caren Goldberg, Robert Gajarski, University of Michigan 
Congenital Heart Center, Ann Arbor, MI
INTRODUCTION: Abnormalities in myocardial function have been documented in sickle
cell anemia (SCA) patients (pts.) using load-dependent indices. Whether the systolic dys-
function results from impaired myocardial contractility or altered loading conditions is
unknown since studies using a load-independent measure of contractility have not been
performed.
PURPOSE: To identify differences in myocardial contractility using the load-independent
end-systolic wall stress (ESSm)-VCFc relationship in SCA pts. compared with age-
matched African American (AA) controls. 
METHODS: 50 healthy AA and 57 SCA pts. 3 mo to 17 yrs were studied. Simultaneous
indirect carotid or brachial pulse tracing, phonocardiogram, ECG, and M-mode tracing of
the LV short-axis were recorded. LV dimensions, ETc, % FS, VCFc, and ESSm were
determined. Using linear regression, the ESSm-VCFc relationship was calculated and
compared between groups.
RESULTS: Age, BSA, and BP were similar between groups. SCA pts. had increased LV
dimensions in systole and diastole, and increased LV mass (p<0.01).
CONCLUSION: SCA pts. have significant LV dilatation consistent with increased preload
and elevated afterload which may contribute to increased ETc and lower FS. Load-inde-
pendent assessment of myocardial function suggests that SCA pts. have reduced con-
tractility compared to controls. These findings may be due to long-standing volume
overload associated with chronic anemia or an effect of microvascular coronary changes
secondary to SCA.
1112-145 Determinants of Severe Pulmonary Hypertension in 
Patients With Severe Aortic Stenosis
Nikhil Kapoor, Padmini Varadarajan, Ramdas G. Pai, Loma Linda University Medical 
Center, Loma Linda, CA
Background: Aortic stenosis (AS) is an increasing problem with the aging population.
Presence of significant pulmonary hypertension in these patients increases the operative
morbidity and mortality. We explored the determinants of severe pulmonary hypertension
in patients with severe AS.
Methods: Our echocardiographic database between 1993 and 2003 was searched for
patients with severe AS defined as a Doppler estimated aortic valve area (AVA) of <0.8
cm2. 949 patients were identified. 626 patients had measurable tricuspid regurgitation
velocity signals forming the study cohort. Doppler estimated pulmonary artery systolic
pressure of >60 mmHg was considered as severe pulmonary hypertension (PHT).
Results: Patient characteristics: age 74+13 years, 50% women, EF 54+20%, AVA
0.74+0.4 cm2. Of the 626 patients, 146 (23%) had severe PHT. Patients with severe PHT
had a smaller AVA (0.65+0.18 vs 0.72+0.19 cm2, p<0.0001) and AVA index (0.37+0.10
vs 0.41+0.11 cm2/m2, p=0.02), lower EF (42+21 vs 56+20%, p<0.0001), larger LV end-
systolic (52+9 vs 49+ 8 mm, p<0.0001) and end-diastolic dimensions (38+10 vs 33+10,
p<0.0001) and a lower relative wall thickness (0.51+0.13 vs 0.56+0.15, p=0.0002). They
also had a greater preponderance of 3 or 4+ mitral regurgitation on a 0-4 scale (55 vs
23%, p<0.001) and a trend towards female preponderance (62 vs 53%, p=0.07). Age, LV
wall thickness and transaortic gradient were not predictive. The independent predictors of
severe PHT were lower EF (p=0.001), greater degree of mitral regurgitation (p=0.0003)
and smaller aortic valve area (p=0.04). In those with EF<40%, the prevalence of severe
PHT was 38% increasing to 52% when AVA was <0.5 cm2.
Conclusions: 1) Severe pulmonary hypetension occurs in about a quarter of patients
with severe AS. 2) It is associated with a smaller AVA, low EF and greater degree of
mitral regurgitation. 3) These findings have implications in the timing of aortic valve
replacement in severe AS.
1112-146 Clinical Predictors and Characteristics of Patients With 
Intra-pulmonary Shunts
Richard A. Santa-Cruz, Matthew D. Pearson, Mauricio G. Cohen, Roshan Shrestha, Park 
W. Willis, IV, Alan Hinderliter, Venu Menon, University of North Carolina, Chapel Hill, NC
Background: Acquired pulmonary arteriovenous shunts are a known complication of
chronic liver disease. A systematic evaluation of the incidence and predictors of intra-pul-
monary shunting (IPS) in patients with liver disease being evaluated for transplantation
has not been previously performed. Methods: We prospectively evaluated for the pres-
ence of IPS in 204 consecutive patients who underwent an echocardiogram with an agi-
tated venous saline contrast bubble study as part of their pre-transplant evaluation. IPS
was diagnosed by the appearance of saline bubbles in the LA after > 3 ventricular beats
post initial appearance in the RA. The shunt size was measured utilizing still frame
images in the apical four chamber view. The bubble count was taken at the heaviest con-
centration still frame and scored using a quantitative scale by two independent observ-
ers. Discordant results were adjudicated by consensus. Results: IPS was documented in
115 out of 204 patients (56.4%). Patients with IPS were more likely to have a history of
alcohol abuse (64.8% vs. 46.9%, p=0.01) and more severe liver disease (Child-Pugh
Class C 72% vs. Class B 54% vs. Class A 44%, p<0.05). No difference was found in alti-
tude of residence for patients with and without IPS (781 vs. 625 feet above sea level
respectively, p=0.11). No differences were also seen in age, sex, body mass index,
smoking, pulmonary function tests, room air PaO2, estimated pulmonary artery pressure,
liver function tests or underlying etiology of liver disease in patients with and without IPS
(all p=NS). Room air PaO2 was significantly higher in patients with Grade 1-2 vs. Grade
3-4 IPS (88mmHg vs. 82mmHg, p<0.04). Two out of 110 (1.8%) patients with evidence of
IPS fulfilled criteria for the Hepatopulomary Syndrome (IPS with liver disease and a PaO2
of less then 60mmHg). Conclusions: The prevalence of IPS in patients with liver dis-
ease was 56.4%. IPS was associated with a history of alcohol abuse and worse class of
liver disease. Increasing IPS grade correlated with worsening room air PaO2. The impact
of IPS positivity and grade on transplant listing and outcomes needs to be determined.
We recommend a saline contrast study should be performed on all patients with liver dis-
ease.
1112-147 Echocardiographic Manifestations of Obstructive Sleep 
Apnea Syndrome at Rest and With Dobutamine: A 
Guide to Effective Medical Management
Antonio Q. Chan, Marietta Abalos Galito, Estrellita Recaro Lua, Noel Antonio, Michael 
Philip Chan, Rosalinda Yutangco Mandreza, Peter Oliver Chan, Zhuo Wen Chen, 
Stanford University Medical Center, Stanford, CA, Chanwell Clinic, Cupertino, CA
Background: Obstructive sleep apnea syndrome (OSA) causes profound disturbance
on cardiovascular physiology. Untreated OSA leads to hypertension that in turn increases
the risks for coronary heart disease, pulmonary hypertension, heart failure and arrhyth-
mias later on in life. We examined the various echocardiographic features on OSA
patients and use these findings to triage patients for aggressive medical management.
Methods: All patients with documented OSA underwent resting echocardiogram (Recho)
and Dobutamine echocardiogram (Decho).265 patients (Male: Female 1.1:1 ages range
32-88) with OSA were entered in the study. Results: Recho: 252 (95%) have diastolic
dysfunction (DDF), 217 (82%) have concentric left ventricular hypertrophy (cLVH), 119
(45%) have pulmonary hypertension (pHPN), 90 (34%) exhibited left ventricular dysfunc-
tion. Decho: 140 (53%) have segmental wall motion abnormality (SWMA), 225 (85%)
have dobutamine-induced left ventricular end-systolic intra-cavitary gradient (LVESG),
maximum gradient range 22-220 mmHg, mean 10-62 mmHg, 69 (26%) have combined
SWMA, and LVESG, 156 (59%) have LVESG but no SWMA. 109 (41%) were shown to
have coronary artery disease by coronary angiogram. DDF and cLVH were present in the
Healthy AA Sickle Cell Anemia p-value
Fractional 
Shortening %
41 +/-4.3 38  +/-5.8 <.01
ETc (msec) 334  +/- 23.7 350  +/- 27.9 <.01
VCFc (circ/s) 1.23 +/- .14 1.09 +/- .19 <.01
ESSm (g/m2) 32.8 +/- 13.5 41.0 +/- 15.3 <.01
ESSm-VCFc 
relationship
VCFc=1.48-
.077(ESSm)R=0.7
VCFc=1.40-
.08(ESSm)R=0.7
<.01
